Form 4 for LAB STANDARD BIOTOOLS INC.
Accepted 2021-11-24 00:00:00 ET · period of report 2021-11-20 · accession 0001162194-21-000097 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-24 | 2021-11-20 | LAB | McCracken Colin | Chief Commercial Off | M - OptEx | $0.00 | +6,519 | 63.5K | +11% | $0 |
| D | 2021-11-24 | 2021-11-20 | LAB | McCracken Colin | Chief Commercial Off | F - Tax | $4.49 | -3,530 | 62.3K | -5% | -$15.8K |
| DM | 2021-11-24 | 2021-11-20 | LAB | McCracken Colin | Chief Commercial Off | M - OptEx | $0.00 | -6,519 | 15.6K | -29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-20 | M | A | 2,598 | $0.00 | 61,932 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-20 | F | D | 3,530 | $4.49 | 62,323 | D | — | — | |
| 3 | Common | Common Stock | 2021-11-20 | M | A | 2,390 | $0.00 | 65,853 | D | — | — | |
| 4 | Common | Common Stock | 2021-11-20 | M | A | 1,531 | $0.00 | 63,463 | D | — | — | |
| 5 | Derivative | Restricted Stock Units | 2021-11-20 | M | D | 2,390 | $0.00 | 21,517 | D | — · — to — | 2,390 Common Stock | (F1) Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. (F4) On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. |
| 6 | Derivative | Restricted Stock Units | 2021-11-20 | M | D | 1,531 | $0.00 | 9,188 | D | — · — to — | 1,531 Common Stock | (F1) Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. (F3) On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. |
| 7 | Derivative | Restricted Stock Units | 2021-11-20 | M | D | 2,598 | $0.00 | 15,587 | D | — · — to — | 2,598 Common Stock | (F1) Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. (F2) On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. |